Cargando…
Kikuchi-Fujimoto Syndrome: A Rare Entity to Consider
INTRODUCTION: Kikuchi-Fujimoto disease (KFD) is a rare, benign, necrotizing lymphadenitis of unknown aetiology with good prognosis. It is characterized by cervical lymphadenopathy, nocturnal diaphoresis and fever. Surgical excision of the adenopathy, histopathological study and immunophenotyping are...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350965/ https://www.ncbi.nlm.nih.gov/pubmed/32665918 http://dx.doi.org/10.12890/2020_001456 |
_version_ | 1783557371089387520 |
---|---|
author | Raposo André, Diogo Vicente, Filipa Chaves, Jessica Caldeira, Mónica Jacinto, Fernando Chaves, António José Brazão, Maria Luz |
author_facet | Raposo André, Diogo Vicente, Filipa Chaves, Jessica Caldeira, Mónica Jacinto, Fernando Chaves, António José Brazão, Maria Luz |
author_sort | Raposo André, Diogo |
collection | PubMed |
description | INTRODUCTION: Kikuchi-Fujimoto disease (KFD) is a rare, benign, necrotizing lymphadenitis of unknown aetiology with good prognosis. It is characterized by cervical lymphadenopathy, nocturnal diaphoresis and fever. Surgical excision of the adenopathy, histopathological study and immunophenotyping are crucial for diagnosis. PATIENTS AND METHODS: This paper describes five patients with three different histological subtypes of KFD, including an atypical presentation masquerading as pyelonephritis and two other cases where physicians mistakenly started chemotherapy. In one other case cytomegalovirus was identified as the responsible aetiological agent, while in the remaining patient, KFD evolved into an autoimmune condition. DISCUSSION: KFD, although rare, may mimic infectious, autoimmune and neoplastic diseases. It also poses a risk for the subsequent development of an autoimmune disorder. LEARNING POINTS: Kikuchi-Fujimoto disease (KFD), although rare, should be included in the differential diagnosis of patients with cervical lymphadenopathy and fever of unknown origin. Early recognition of KFD may minimize the use of unnecessary aggressive examinations and therapies. The course of KFD in most patients is self-limiting, but there is a risk of progression to an autoimmune syndrome. |
format | Online Article Text |
id | pubmed-7350965 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SMC Media Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-73509652020-07-13 Kikuchi-Fujimoto Syndrome: A Rare Entity to Consider Raposo André, Diogo Vicente, Filipa Chaves, Jessica Caldeira, Mónica Jacinto, Fernando Chaves, António José Brazão, Maria Luz Eur J Case Rep Intern Med Articles INTRODUCTION: Kikuchi-Fujimoto disease (KFD) is a rare, benign, necrotizing lymphadenitis of unknown aetiology with good prognosis. It is characterized by cervical lymphadenopathy, nocturnal diaphoresis and fever. Surgical excision of the adenopathy, histopathological study and immunophenotyping are crucial for diagnosis. PATIENTS AND METHODS: This paper describes five patients with three different histological subtypes of KFD, including an atypical presentation masquerading as pyelonephritis and two other cases where physicians mistakenly started chemotherapy. In one other case cytomegalovirus was identified as the responsible aetiological agent, while in the remaining patient, KFD evolved into an autoimmune condition. DISCUSSION: KFD, although rare, may mimic infectious, autoimmune and neoplastic diseases. It also poses a risk for the subsequent development of an autoimmune disorder. LEARNING POINTS: Kikuchi-Fujimoto disease (KFD), although rare, should be included in the differential diagnosis of patients with cervical lymphadenopathy and fever of unknown origin. Early recognition of KFD may minimize the use of unnecessary aggressive examinations and therapies. The course of KFD in most patients is self-limiting, but there is a risk of progression to an autoimmune syndrome. SMC Media Srl 2020-04-27 /pmc/articles/PMC7350965/ /pubmed/32665918 http://dx.doi.org/10.12890/2020_001456 Text en © EFIM 2020 This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Articles Raposo André, Diogo Vicente, Filipa Chaves, Jessica Caldeira, Mónica Jacinto, Fernando Chaves, António José Brazão, Maria Luz Kikuchi-Fujimoto Syndrome: A Rare Entity to Consider |
title | Kikuchi-Fujimoto Syndrome: A Rare Entity to Consider |
title_full | Kikuchi-Fujimoto Syndrome: A Rare Entity to Consider |
title_fullStr | Kikuchi-Fujimoto Syndrome: A Rare Entity to Consider |
title_full_unstemmed | Kikuchi-Fujimoto Syndrome: A Rare Entity to Consider |
title_short | Kikuchi-Fujimoto Syndrome: A Rare Entity to Consider |
title_sort | kikuchi-fujimoto syndrome: a rare entity to consider |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350965/ https://www.ncbi.nlm.nih.gov/pubmed/32665918 http://dx.doi.org/10.12890/2020_001456 |
work_keys_str_mv | AT raposoandrediogo kikuchifujimotosyndromearareentitytoconsider AT vicentefilipa kikuchifujimotosyndromearareentitytoconsider AT chavesjessica kikuchifujimotosyndromearareentitytoconsider AT caldeiramonica kikuchifujimotosyndromearareentitytoconsider AT jacintofernando kikuchifujimotosyndromearareentitytoconsider AT chavesantoniojose kikuchifujimotosyndromearareentitytoconsider AT brazaomarialuz kikuchifujimotosyndromearareentitytoconsider |